HALO logo
halo search icon
CG Oncology, Inc.

US$64.59

Price Change Indicator
-0.17 (-0.263%)
CG Oncology, Inc.
CGON · NAS

CG Oncology, Inc.

Start Trading CGON for Free

US$64.59

Price Arrow-0.17 (-0.263%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CG Oncology, Inc. Overview

CGON Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About CGON

icon

Website

CG Oncology, Inc.

icon

Telephone

1.949.409.3700

icon

Address

Suite 2040, 400 Spectrum Center Drive, Irvine, CA 92618

Description

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.

CGON Price Chart

Key Stats

Market Cap

US$5.71B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 23.65 - 75.5

Trade Value (12mth)

US$11,887,592.00

1 week

-3.24%

1 month

-7.33%

YTD

54.97%

1 year

151.4%

All time high

75.50

Key Fundamentals

EPS 3 yr Growth

216.90%

EBITDA Margin

NaN%

Operating Cashflow

-$132m

Free Cash Flow Return

-17.70%

ROIC

-21.60%

Interest Coverage

0.00

Quick Ratio

24.60

Other Data

Shares Outstanding (Fully Diluted)

85m

HALO Sector

Healthcare

Next Company Report Date

26-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CGON Announcements

Latest Announcements

DateAnnouncements
09 May 26
09 May 26
08 May 26
08 May 26
08 May 26

CGON Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.02-1.16-2.08locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.02-1.16-2.08locklocklock
Growth
 %locklocklocklock-54.8-13.6-80.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of CG Oncology, Inc. (CGON:NAS)?
Halo FAQ
The current share price of CG Oncology, Inc. (CGON:NAS) is USD$64.59.
What is the 52-week high share price for CG Oncology, Inc. (CGON:NAS)?
Halo FAQ
The 52-week high share price for CG Oncology, Inc. (CGON:NAS) is USD$75.50.
What is the 52-week low share price for CG Oncology, Inc. (CGON:NAS)?
Halo FAQ
The 52-week low share price for CG Oncology, Inc. (CGON:NAS) is USD$23.65.
What is the dividend yield for CG Oncology, Inc. (CGON:NAS)?
Halo FAQ
CG Oncology, Inc. (CGON:NAS) does not pay a dividend.
What was CG Oncology, Inc. (CGON:NAS) last dividend payment?
Halo FAQ
CG Oncology, Inc. (CGON:NAS) does not pay a dividend.
What is the franking level for CG Oncology, Inc. (CGON:NAS)?
Halo FAQ
CG Oncology, Inc. (CGON:NAS) has a franking level of 0.00%.
In which sector is CG Oncology, Inc. (CGON:NAS) classified?
Halo FAQ
CG Oncology, Inc. (CGON:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial